Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Spironolactone and Furosemide
Trade Name
Lasilactone 50
Risk Category
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
The risk category is C for Furosemide.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

  • diuretic (potassium Sparing +loop diuretic).
  • Fetal Risk
    Fetal Risk
  • Spironolactone causes feminization of male fetuses in animals. No adequate human data but suggested possible association with oral clefts in 1st trimester exposure. Contra indicated in pregnancy because of its antiandrogenic effect resulting in feminization of male fetuses.
  • No well-controlled human data for Furosemide, suggested possible association with hypospadias in 1st trimester exposure.
  • No fetal adverse effects if used in the last two trimesters but it can induce diuresis in the newborns.
  • Breast Feeding
    Breast Feeding
  • Both agents are excreted into human milk. Spironolactone is safe.
  • No adverse effects have been reported with Furosemide.
  • Other Trade Names
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        Your Friend
     7   +   10    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Month Day Year